Diabetes Canada

Diabetes Canada awards over $6 million in funding to new research projects

Retrieved on: 
Monday, January 22, 2024
Diabetes, Health, B cell, Research, Diabetes Canada, Daisy Syron Russell, Risk, Leg, Type 2 diabetes, Nix, Caregiver, Insulin resistance, Prediabetes, Pharmaceutical industry

Each research project receives a $100,000 grant annually for three years for a total of $6.2 million in funds committed by Diabetes Canada for the research community.

Key Points: 
  • Each research project receives a $100,000 grant annually for three years for a total of $6.2 million in funds committed by Diabetes Canada for the research community.
  • “To achieve our vision of a world free of the effects of diabetes, Diabetes Canada knows that it needs to harness the transformative and combined power of technological, medical, and scientific research,” says Laura Syron, President and CEO of Diabetes Canada.
  • The winning research projects for this year’s Diabetes Canada’s End Diabetes Awards were rigorously evaluated by scientists with expertise in diabetes research, with input from people with lived experience, and Diabetes Canada’s National Research Council.
  • For almost 50 years, Diabetes Canada has proudly supported outstanding diabetes research in Canada, administering more than $160 million in research grants, awards and partnerships to scientists and clinicians who have dedicated their careers to the fight against diabetes.

Switch Health develops Canada’s first at-home diagnostic Diabetes test

Retrieved on: 
Thursday, November 30, 2023
Patient, Purolator, Glucose, Interview, Risk, Death, STI, Kidney, Insulin, Diabetes Canada, Diabetes, HPV, Glycated hemoglobin, Hospital, Kidney disease, DBS, A1C, CSI: Vegas, Cell, Cardiovascular disease, Medical device

Switch Health's innovative at-home HbA1c test allows people with diabetes or those suspecting the condition to collect Dry Blood Spot (DBS) samples at home.

Key Points: 
  • Switch Health's innovative at-home HbA1c test allows people with diabetes or those suspecting the condition to collect Dry Blood Spot (DBS) samples at home.
  • To get started, users can visit the Switch Health website, select the HbA1c test kit, and complete an intake form, which determines medical necessity and public coverage of test processing (currently only for Ontario residents.)
  • According to Diabetes Canada , people living with diabetes face a higher risk of hospitalization due to cardiovascular disease and end-stage renal disease.
  • This marks Switch Health's latest at-home, self-collected test, following the introduction of at-home HPV and STI testing kits this fall.

“We’re never off the clock”: Diabetes Canada launches Let’s Make Time campaign for Diabetes Awareness Month

Retrieved on: 
Wednesday, November 1, 2023
Knowledge, Attention, Social media, Education, Banting House, Life, Family, Diabetes Canada, Pet, Diabetes, Type 2 diabetes, Friends, Prediabetes, Learning, Medicine, Nobel Prize, T1D, World Diabetes Day, Insulin, Pharmaceutical industry, Physiology, Circle

“When it comes to managing diabetes, we’re never off the clock,” says Laura Syron, President & CEO of Diabetes Canada, who lives with type 2 diabetes.

Key Points: 
  • “When it comes to managing diabetes, we’re never off the clock,” says Laura Syron, President & CEO of Diabetes Canada, who lives with type 2 diabetes.
  • What I want people to know most of all is, we didn’t do this to ourselves,” Amy Moore says.
  • Receive practical daily themed emails delivered right to your inbox from November 14 to 17, and then attend an exciting half-day virtual event on November 18.
  • This November let’s make time for Diabetes Awareness Month.

#Dynacare4Diabetes Returns with Free Diabetes Testing for Greater Toronto Area

Retrieved on: 
Wednesday, November 1, 2023
Franco-Ontarians, Diabetes Canada, Diabetes, Organization, Type 2 diabetes, GTA, Prediabetes, Disease, Risk, Labcorp, Diagnosis, Pharmaceutical industry, Medical device, Dynacare, Greater Toronto Area

According to Diabetes Canada [1] , more than 3.7 million people in Canada are currently living with type 2 diabetes.

Key Points: 
  • According to Diabetes Canada [1] , more than 3.7 million people in Canada are currently living with type 2 diabetes.
  • A more sobering statistic in Canada is that 1.7 million people are estimated to be living with type 2 diabetes without knowing it.
  • Type 2 diabetes is a disease that can be managed through lifestyle changes and, in some cases, medication.
  • #Dynacare4Diabetes urges people to act by first assessing their risk factors for developing type 2 diabetes with a quick online quiz .

Government of Canada invests nearly $1 million to support activities to address diabetes in Canada

Retrieved on: 
Monday, June 26, 2023
Public Health Agency of Canada, Diabetes Canada, The Honourable, Diabetes, Education, Gestational diabetes, Public, Policy, Cancer, Quality of life, Risk, Sonia, Parliament, Organization, Hypertension, National Lottery Community Fund, Conditional sentence, Research, Public Health Agency, Smoking, Pharmaceutical industry, Dietary supplement, Framework, First Nations, Health

This funding will allow Diabetes Canada to work with key partners to develop an inventory of successful diabetes programs, interventions, and projects to support the subsequent dissemination, adoption, and customization of these initiatives across the country.

Key Points: 
  • This funding will allow Diabetes Canada to work with key partners to develop an inventory of successful diabetes programs, interventions, and projects to support the subsequent dissemination, adoption, and customization of these initiatives across the country.
  • The funding announced today is aligned with the Framework for Diabetes in Canada , which provides a common policy direction to focus efforts to address diabetes and to ensure better health outcomes for people in Canada.
  • Diabetes Canada will advance the Framework for Diabetes in Canada by convening individuals living with diabetes, key leaders in public health, diabetes care and education, as well as cultural leaders and organizations, to share innovative and best practices to identify, prevent, and manage diabetes.
  • Together with Diabetes Canada, we will strengthen our efforts to better recognize, collaborate with, and support those living with diabetes in Canada.

Sandoz Canada improves patients’ access to treatment with the launch of three new generics

Retrieved on: 
Wednesday, May 17, 2023
Myelodysplastic syndrome, Exercise, Diabetes Canada, Diet, Heart failure, QC, Hospital, Hypocalcemia, COVID-19, Type 2 diabetes, Commonwealth of Australia (US securities entity), Medicine, Research, Sale, Novartis, Osteodystrophy, MS, Acute myeloid leukemia, Trial of the century, Alfacalcidol, Vitamin D, Capsule, AML, Patient, Cost, Risk, Prevalence, Blister, Kidney disease, Hematopoietic stem cell transplantation, Pharmaceutical industry, Diabetes

The medicine is available in 0.25 mcg and 1 mcg blisters of 100 capsules as is the original product.

Key Points: 
  • The medicine is available in 0.25 mcg and 1 mcg blisters of 100 capsules as is the original product.
  • Thanks to the launch, this therapy will now be more accessible for patients in Canada.
  • With this launch, Sandoz Canada is a proud to offer even more treatment options for diabetic patients in Canada.
  • ® Registered trademark owned or used under license by Sandoz Canada Inc.
    * Registered trademark owned by its respective registrant.

PHARMASAVE'S NEW CEO EXCITED TO BUILD A PLAN FOR FUTURE GROWTH AND SUCCESS

Retrieved on: 
Tuesday, March 28, 2023
Diabetes Canada, International, Pharmacy, Marketing, National Management Association, Curling Canada, General Mills, Chairperson, Growth, Health, Pharmasave, Management, Nursing

Working collaboratively with the executive leadership team, Ivan's initial priority will be building a plan for Pharmasave's future growth and continued success.

Key Points: 
  • Working collaboratively with the executive leadership team, Ivan's initial priority will be building a plan for Pharmasave's future growth and continued success.
  • Board Chair and President Michael Ibrahim says, "I am delighted to introduce our new CEO, Ivan Guillen.
  • He has hit the ground running: in only a few weeks, his ideas have infused our organization with energy, strengthening our programs.
  • Ivan brings extensive North American and International experience and has been an immediate fit with our National Management and Executive teams.

New report points to rising out-of-pocket costs for people living with diabetes in Canada

Retrieved on: 
Wednesday, February 22, 2023
Type 2 diabetes, Diabetes Canada, Diabetes, Insulin, Food, Housing, Blood, Commons, Pregnancy, Canadian House of Commons Standing Committee on Human Resources, Skills and Social Development and the Status of Persons with Disabilities, Government, AHT, House, Health, Pharmaceutical industry, Health insurance, Medical device

Toronto, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Too many people living with diabetes in Canada are paying increasing costs for prescribed medications, devices, or supplies, according to Diabetes Canada’s new report on diabetes-related out-of-pocket costs .

Key Points: 
  • Toronto, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Too many people living with diabetes in Canada are paying increasing costs for prescribed medications, devices, or supplies, according to Diabetes Canada’s new report on diabetes-related out-of-pocket costs .
  • While government support is highest for low-income groups, the proportion of family income required to cover costs is also the highest for these groups.
  • In certain parts of Canada, out-of-pocket costs can be as high as $10,014 per year for people with type 2 diabetes.
  • Out-of-pocket diabetes costs are often impossible.”
    In certain parts of Canada, out-of-pocket costs can be as high as $18,306 per year for people with type 1 diabetes.

Successful Newtopia and Medtronic Lifestyle Intervention Pilot to Address Prevalence of Type 2 Diabetes Exceeds Expectations in Newfoundland and Labrador

Retrieved on: 
Tuesday, February 7, 2023
National Directorate of Intelligence and Prevention Services, Eastern Health Alliance, Korea Disease Control and Prevention Agency, Prediabetes, Economics, Human, A, Medtronic, Patient, Prevalence, Fry, Type 2 diabetes, Health, Risk, Partnership, Government procurement in the European Union, A1C, Type 2, Habit, Quality of life, Diabetes Canada, Dietary supplement, Pharmaceutical industry, Eastern Health, Diabetes, Marion Cotillard

Weight loss trends among participants showed a decrease from a baseline of 3.5% of body weight at 6 months and 6.4% at 10 months.

Key Points: 
  • Weight loss trends among participants showed a decrease from a baseline of 3.5% of body weight at 6 months and 6.4% at 10 months.
  • We entered a strategic partnership with Medtronic and Newtopia to implement a pilot project to procure an outcome for diabetes management.
  • We are confident that alongside Medtronic, we will continue to deliver better diabetes health outcomes across Canadian Provinces."
  • 1Estimated Prevalence and Cost of Diabetes in Newfoundland and Labrador, Canadian Diabetes Association, 2023.

Diabetes Canada awards $9 million in funding to 30 new research projects

Retrieved on: 
Tuesday, January 17, 2023
National Research Council, Immune system, Population health, Quality of life, Diabetes, Diabetes Canada, Health, Research, Pharmaceutical industry

Toronto, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Diabetes Canada is proud to announce the winners of our End Diabetes Awards research competition .

Key Points: 
  • Toronto, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Diabetes Canada is proud to announce the winners of our End Diabetes Awards research competition .
  • “Canada has a well-earned reputation for innovation in diabetes treatment and care that has dramatically improved the quality of life for people with diabetes,” says Laura Syron, President and CEO of Diabetes Canada.
  • That is why Diabetes Canada has committed $9 million in funds to the research community, ensuring that each of these 30 promising projects receive a $100,000 grant annually for three years.
  • Diabetes Canada currently supports 55 research projects from 15 research institutions and labs located across the country.